Delivery Order SPE2DB22D6029-SPE2DB24FU0NR
- Not listed
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order worth $2,261.31 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide YUPELRI 175 MCG/3 ML SOLUTION UD 3ML. This delivery order is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for...
- This is a $16,095.56 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of YUPELRI 175 MCG/3 ML SOLUTION UD 3ML, a pharmaceutical product. The contract has a period of performance through December 20, 2024. It is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,389.28, is for the supply of YUPELRI 175 MCG/3 ML SOLUTION UD 3ML, a medical product, with a period of performance through June 13, 2024. The contract has a firm fixed price pricing type and is not associated with any set-aside designation, indicating open...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,358.18, is for the supply of YUPELRI 175 MCG/3 ML SOLUTION UD 3ML, a medical product. The contract has a firm fixed price pricing type and an ultimate completion date of June 24, 2024. This award is not associated with a set-aside designation. AmerisourceBergen holds a...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of YUPELRI 175 MCG/3 ML SOLUTION UD 3ML, a pharmaceutical product, with a ceiling value of $3,330.74 and an ultimate completion date of May 22, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
- This is a delivery order awarded under an Indefinite Delivery Contract (IDC) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,213.11 firm fixed-price contract is to provide the drug YUPELRI 175 MCG/3 ML SOLUTION UD 3ML to the Defense Logistics Agency (DLA). The contract has an ultimate completion date of March 19, 2024. AmerisourceBergen holds a $999,999,999 IDC with the DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive range...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,224.99, is a delivery order for the drug YUPELRI 175 MCG/3 ML SOLUTION UD 3ML. The contract has an ultimate completion date of April 9, 2025 and utilizes a firm fixed price pricing type. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $8,083.44 firm fixed-price delivery order is for the pharmaceutical product "YUPELRI 175 MCG/3 ML SOLUTION UD 3ML". The contract has an ultimate completion date of April 24, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025. This...
- This federal contract award is for the delivery of YUPELRI 175 MCG/3 ML SOLUTION UD 3ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $3,450.25 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on August 12, 2024, with a completion date of August 13, 2024. The contract is not set aside and is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical,...
- This federal contract award, valued at $10,802.03, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order for the pharmaceutical product YUPELRI 175 MCG/3 ML SOLUTION UD 3ML, with an ultimate completion date of October 10, 2024. This award does not have a set-aside designation. Amerisourcebergen, through its Corporate Office Division, has been awarded numerous federal contracts to supply a wide range...
- SPE2DB22D6029Indefinite Delivery Contract
- SPE2DB22D6029-SPE2DB24FU0NRDelivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product YUPELRI 175 MCG/3 ML SOLUTION UD 3ML. The contract has a ceiling value of $1,354.52 and a period of performance through April 10, 2024. This delivery order contract is issued under a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded by DLA to Amerisourcebergen Drug Corp as a single award. The IDC serves as the primary contract vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this contract award.